Remove Biomarkers Remove Innovation Remove Patient Care
article thumbnail

RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring

DAIC

RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. This is an innovative platform for measuring biomarkers,” stated Dr. Karlsberg.

article thumbnail

Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle

Journal of the American Heart Association

Despite significant advances in the diagnosis, prognostication, and treatment of thrombotic diseases over the past 3 decades, the adoption of findings stemming from translational biomarker research in clinical practice remains limited. They hold the promise of revolutionizing patient care.

article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

For 19 years, the Cardiometabolic Health Congress (CMHC) has worked towards a vision of a better future for clinicians, patients, and the entire health sector. This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L.

Education 100
article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.

CME 64
article thumbnail

Top 10 Cardiac Diagnosis Trends in 2024

GEMMS

Additionally, integrating smart point-of-care tests (POCTs) and digital health applications has notably improved clinical diagnosis, streamlining the monitoring and management of cardiac health in home and remote healthcare settings. GEMMSOne integrates this data into patient records, helping clinicians use objective metrics for diagnosis.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. One promising strategy is the formation of creative partnerships between patients and their healthcare teams. Key contributions: Advanced cardiac imaging (e.g.,